| 1. | Application of homocysteine as a non-invasive and effort-free measurements for risk assessment of patients with pulmonary hypertension.Wang MT, Chi PL, Cheng CC, Huang WC, Chen LW.Cardiol J. 2023 Sep 29. doi: 10.5603/cj.92813. Online ahead of print.PMID: 37772357 Free article. |
| 2. | MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension.Chi PL, Cheng CC, Hung CC, Wang MT, Liu HY, Ke MW, Shen MC, Lin KC, Kuo SH, Hsieh PP, Wann SR, Huang WC.Int J Biol Sci. 2022 Jan 1;18(1):331-348. doi: 10.7150/ijbs.66472. eCollection 2022.PMID: 34975336 Free PMC article. |
| 3. | Gene Mutation Annotation and Pedigree for Pulmonary Arterial Hypertension Patients in Han Chinese Patients.Wang MT, Charng MJ, Chi PL, Cheng CC, Hung CC, Huang WC.Glob Heart. 2021 Oct 18;16(1):70. doi: 10.5334/gh.1002. eCollection 2021.PMID: 34900561 Free PMC article. |
| 4. | P2X7 receptor blockade reduces pyroptotic inflammation and promotes phagocytosis in Vibrio vulnificus infection.Wann SR, Lo HR, Chang YT, Liao JB, Wen ZH, Chi PL.J Cell Physiol. 2023 Oct;238(10):2316-2334. doi: 10.1002/jcp.31114. Epub 2023 Sep 19.PMID: 37724600 |
| 5. | Creation of Chitosan-Based Nanocapsule-in-Nanofiber Structures for Hydrophobic/Hydrophilic Drug Co-Delivery and Their Dressing Applications in Diabetic Wounds.Lin ZI, Tsai TH, Yu KC, Nien YH, Liu RP, Liu GL, Chi PL, Fang YP, Ko BT, Law WC, Zhou C, Yong KT, Cheng PW, Chen CK.Macromol Biosci. 2023 Oct;23(10):e2300145. doi: 10.1002/mabi.202300145. Epub 2023 Jun 17.PMID: 37279400 |